IRIS UniCatt

Pagano, Livio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.255
AS - Asia 11.113
EU - Europa 10.733
SA - Sud America 2.223
AF - Africa 301
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 9
Totale 37.657
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.887
SG - Singapore 5.173
DE - Germania 3.638
CN - Cina 2.720
BR - Brasile 1.812
SE - Svezia 1.530
IT - Italia 1.162
FR - Francia 928
VN - Vietnam 859
UA - Ucraina 840
IE - Irlanda 534
IN - India 500
GB - Regno Unito 447
NL - Olanda 447
ID - Indonesia 366
RU - Federazione Russa 305
FI - Finlandia 291
JP - Giappone 244
PL - Polonia 233
HK - Hong Kong 200
TR - Turchia 182
IQ - Iraq 160
AR - Argentina 143
BD - Bangladesh 143
MX - Messico 142
CA - Canada 138
KR - Corea 80
ZA - Sudafrica 75
ES - Italia 74
PK - Pakistan 73
AT - Austria 67
SA - Arabia Saudita 65
EC - Ecuador 61
VE - Venezuela 50
EG - Egitto 46
BE - Belgio 45
CO - Colombia 44
JO - Giordania 39
CL - Cile 38
KE - Kenya 36
MA - Marocco 34
UZ - Uzbekistan 34
IL - Israele 32
AE - Emirati Arabi Uniti 27
CZ - Repubblica Ceca 25
KZ - Kazakistan 25
CI - Costa d'Avorio 24
PY - Paraguay 24
RO - Romania 24
LT - Lituania 23
PH - Filippine 22
AU - Australia 19
JM - Giamaica 19
AZ - Azerbaigian 17
CH - Svizzera 17
IR - Iran 17
MY - Malesia 17
PE - Perù 17
TH - Thailandia 16
TN - Tunisia 16
BO - Bolivia 15
UY - Uruguay 15
DZ - Algeria 14
NP - Nepal 14
CR - Costa Rica 12
AL - Albania 11
ET - Etiopia 11
GR - Grecia 11
MD - Moldavia 11
NG - Nigeria 11
DO - Repubblica Dominicana 10
HU - Ungheria 10
OM - Oman 10
PS - Palestinian Territory 10
AM - Armenia 9
BH - Bahrain 9
LV - Lettonia 8
PA - Panama 8
AO - Angola 7
DK - Danimarca 7
EU - Europa 7
HN - Honduras 7
SN - Senegal 7
TT - Trinidad e Tobago 7
BG - Bulgaria 6
GT - Guatemala 6
HR - Croazia 6
LY - Libia 6
BY - Bielorussia 5
GE - Georgia 5
KG - Kirghizistan 5
LA - Repubblica Popolare Democratica del Laos 5
LB - Libano 5
NI - Nicaragua 5
NO - Norvegia 5
QA - Qatar 5
BB - Barbados 4
LK - Sri Lanka 4
TW - Taiwan 4
BA - Bosnia-Erzegovina 3
Totale 37.586
Salva come PNG Salva come JPEG
Città #
Singapore 2.604
Chandler 1.635
Ashburn 1.444
San Jose 1.340
Jacksonville 532
Dublin 524
Beijing 447
San Mateo 403
Amsterdam 372
Jakarta 337
Lauterbourg 317
Ann Arbor 312
Ho Chi Minh City 308
Hefei 306
Frankfurt am Main 302
New York 299
Wilmington 286
Los Angeles 278
Nanjing 278
Milan 223
Hanoi 221
Dearborn 220
Chicago 210
Tokyo 210
Boston 205
Munich 202
Houston 196
Rome 193
Hyderabad 191
Warsaw 191
Nürnberg 186
Hong Kong 185
Moscow 184
Woodbridge 183
Lawrence 170
São Paulo 166
Bremen 158
Hangzhou 158
St Louis 148
Cattolica 129
Dallas 129
Buffalo 119
Zhengzhou 117
Princeton 103
The Dalles 93
Marseille 92
Nanchang 91
Santa Clara 91
Seattle 91
Council Bluffs 89
Redwood City 88
Kent 83
Izmir 81
Fairfield 78
Seoul 75
Shanghai 72
Boardman 70
Nuremberg 70
Redmond 69
Paris 63
Rio de Janeiro 63
Shenyang 61
Mountain View 60
Tianjin 60
Baghdad 59
Orem 59
Hebei 58
Kunming 53
Lancaster 51
Brooklyn 48
Norwalk 45
Changsha 44
Brussels 43
University Park 43
Helsinki 42
Jiaxing 42
Mexico City 42
Toronto 42
Belo Horizonte 41
Guangzhou 41
Da Nang 39
London 38
Phoenix 38
Philadelphia 37
Washington 37
Amman 36
Chennai 35
Leawood 35
Montreal 35
Atlanta 33
Dhaka 33
Cambridge 32
Haiphong 31
Nairobi 31
Poplar 31
Turku 31
Brasília 30
Düsseldorf 30
Lappeenranta 30
San Francisco 30
Totale 19.686
Salva come PNG Salva come JPEG
Nome #
Long-term follow-up of cladribine treatment in hairy cell leukemia: 30-year experience in a multicentric Italian study 586
5-azacytidine in chronic myelomonocytic leukemia: case report and review of literature 430
Incidence of acute myeloid leukemia after breast cancer 381
Factors associated with mortality in bacteremic patients with hematologic malignancies. 374
Reliability of leukostasis grading score to identify patients with high-risk hyperleukocytosis 371
Factors associated with mortality in bacteremic patients with haematologic malignancies 355
Posttransplant lymphoproliferative disorders after liver transplantation: analysis of early and late cases in a 255 patient series 350
A prospective survey of febrile events in hematological malignancies 303
Therapy-related leukemias and myelodysplasia : susceptibility and incidence. 279
A cluster of Geotrichum clavatum (Saprochaete clavata) infection in haematological patients: a first Italian report and review of literature 262
Prospective study of hepatitis B virus reactivation in patients with hematological malignancies 227
Systemic granulomatous reaction secondary to treatment of bladder cancer with Bacillus Calmette-Guerin 222
Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. 220
Factors associated with mortality in bacteremic patients with hematologic malignancies. 218
Diagnosis of invasive aspergillosis by a commercial real-time PCR assay for Aspergillus DNA in bronchoalveolar lavage fluid samples from high-risk patients compared to a galactomannan enzyme immunoassay 210
Gemtuzumab ozogamicin, citosine arabinoside, G-CSF combination (G-AraMy) in the treatment of elderly patients with poor-prognosis acute myeloid leukemia. 209
Impaired bactericidal and fungicidal activities of neutrophils in patients with myelodysplastic syndrome 196
Carbapenemase-producing Klebsiella pneumoniae and hematologic malignancies 196
Increased risk of acute myeloid leukaemia due to polymorphisms in detoxification and DNA repair enzymes. 192
The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. 192
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the italian network on secondary leukemias. 187
Comparative performance evaluation of Wako β-glucan test and Fungitell assay for the diagnosis of invasive fungal diseases 183
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 182
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 180
Epigenetic changes in therapy-related MDS/AML 179
Antithrombin III in full-term and pre-term newborn infants: three cases of neonatal diagnosis of AT III congenital defect 177
Dose-Dependent Effect of Granulocyte Transfusions in Hematological Patients with Febrile Neutropenia 172
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 171
Similarities and differences between therapy-related and elderly acute myeloid leukemia 170
Polymorphisms of detoxification and DNA repair enzymes in myelodyplastic syndromes 167
Changes in the incidence of candidemia and related mortality in patients with hematologic malignancies in the last ten years. A SEIFEM 2015-B report 166
All-trans retinoic acid in association with low dose cytosine arabinoside in the treatment of acute myeoid leukemia in elderly patients 166
Adherence to international guidelines for the treatment of invasive aspergillosis in acute myeloid leukaemia: feasibility and utility (SEIFEM-2008B study). 165
Primary plasma cell leukemia followed by testicular plasmacytoma 164
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 159
Invasive aspergillosis in patients with acute myeloid leukemia: SEIFEM-2008 registry study. 159
Hyperleukocytosis and leukostasis: management of a medical emergency 159
Serum beta 2 microglobulin in psoriasis and psoriatic patients 158
A prospective survey of febrile events in hematological malignancies 155
Extramedullary Involvement in Acute Myeloid Leukemia. A Single Center Ten Years' Experience 155
. Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies. 154
Imatinib plus steroids induces complete remissions and prolonged survival in elderly Philadelphia chromosome-positive patients with acute lymphoblastic leukemia without additional chemotherapy: results of the Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) LAL0201-B protocol. 153
Adjuvant therapy with rhGM-CSF for the treatment of Blastoschizomyces capitatus systemic infection in a patient with acute myeloid leukemia 153
Tumor lysis syndrome: review of pathogenesis, risk factors and management of a medical emergency 152
A T cell lymphoblastic lymphoma with mucormycosis as unusual etiology of acute cerebral ischemia 152
Hema e-Chart: Italian Registry for prospective analysis of epidemiology, management and outcome of febrile events in patients with hematological malignancies 151
Pre-chemotherapy risk factors for invasive fungal diseases: prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (SEIFEM 2010-a multicenter study) 151
Atypical presentation of progressive multifocal leukoencephalopathy in a multiple myeloma patient after auto SCTsuccessfully treated with combination treatment. 150
A prospective survey of febrile events in hematological malignancies 149
Advanced mast cell disease: an Italian Hematological Multicenter experience. 148
Derivation and validation of a scoring system to identify patients with bacteremia and hematological malignancies at higher risk for mortality 148
Evaluation of the practice of antifungal prophylaxis use in patients with newly diagnosed acute myeloid leukemia: results from the SEIFEM 2010-B registry 148
Carbapenemase-producingKlebsiella pneumoniaeand Hematologic Malignancies 148
Risk of invasive fungal infection in patients affected by acute promyelocytic leukaemia. A report by the SEIFEM-D registry 148
Treatment of primary plasma cell leukemia with high doses of cyclophosphamide, bortezomib, and dexamethasone followed by double autologous HSCT 147
Derivation and Validation of a Scoring System to Identify Patients with Bacteremia and Hematological Malignancies at Higher Risk for Mortality 146
ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients 146
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 146
Hyperleukocytosis and leukostasis: management of a medical emergency 146
Systemic antifungal treatment after posaconazole prophylaxis: results from the SEIFEM 2010-C survey 145
Granulocyte transfusions as adjunctive treatment of invasive fungal diseases in neutropenic patients 144
Immature platelet fraction (IPF) in hospitalized patients with neutrophilia and suspected bacterial infection 143
In vitro Effect of Eltrombopag Alone and in Combination With Azacitidine on Megakaryopoiesis in Patients With Myelodysplastic Syndrome 143
Candidaemia in haematological malignancy patients from a SEIFEM study: Epidemiological patterns according to antifungal prophylaxis 143
Invasive aspergillosis in relapsed/refractory acute myeloid leukaemia patients: Results from SEIFEM 2016-B survey 143
Frontline chemotherapy with bortezomib-containing combinations improves response rate and survival in primary plasma cell leukemia: a retrospective study from GIMEMA Multiple Myeloma Working Party 140
A patient with acute myeloid leukemia and a solid mass in the colon. 139
Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia 139
Outcome of therapy-related myeloid neoplasms treated with azacitidine 137
Invasive fungal infections in chronic lymphoproliferative disorders: A monocentric retrospective study 137
Tunneling Schmorl?s Nodes in an Elderly Woman Treated for Acute Lymphoblastic Leukemia. 136
Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study 136
SEIFEM 2017: from real life to an agreement on the use of granulocyte transfusions and colony-stimulating factors for prophylaxis and treatment of infectious complications in patients with hematologic malignant disorders 135
Temsirolimus, an mTOR inhibitor, in combination with lower-dose clofarabine as salvage therapy for older patients with acute myeloid leukaemia: results of a phase II GIMEMA study (AML-1107) 133
Scedosporiosis in patients with acute leukemia: a retrospective multicenter report 133
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the Italian network on secondary leukemias 133
The use and efficacy of empirical versus pre-emptive therapy in the management of fungal infections: the HEMA e-Chart Project 132
Uncommon yeast infections in hematological patients: from diagnosis to treatment 132
Bloodstream infections caused by Escherichia coli in onco-haematological patients: Risk factors and mortality in an Italian prospective survey 132
Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic: Results from the EPICOVIDEHA registry 131
Invasive Aspergillosis in patients with acute leukemia: update on morbidity and mortality--SEIFEM-C Report. 131
Efficacy of combined surgery and antifungal therapies for the management of invasive zygomycoses in patients with haematological malignancies 131
COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA) 131
The use and efficacy of empirical versus pre-emptive therapy in the management of fungal infections: the HEMA e-Chart Project 130
SIMIFF study: Italian fungal registry of mold infections in hematological and non-hematological patients 130
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey 129
Caspofungin for the treatment of candidaemia in patients with haematological malignancies 128
Risk stratification for invasive fungal infections in patients with hematological malignancies: SEIFEM recommendations 128
First case of breakthrough pneumonia due to Aspergillus nomius in a patient with acute myeloid leukemia 127
Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia 127
In vitro susceptibility of Candida species isolated from patients with haematological malignancies 126
High prevalence of hepatitis B virus infection in B-cell non-Hodgkin's lymphoma. 125
Negative prognostic value of glutathione s-transferase (gstm1 and gstt1) deletions in adult acute myeloid leukemia. 125
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey 123
Systemic antifungal treatment after posaconazole prophylaxis: results from the SEIFEM 2010-C survey 121
Blastic plasmacytoid dendritic cell neoplasm: diagnostic criteria and therapeutical approaches 121
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 121
Reduction of hospitalization and transfusion support in patients with acute promyelocytic leukemia treated with arsenic trioxide plus all-trans retinoic acid compared to chemotherapy plus all-trans retinoic acid 121
COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA) 120
Treatment strategies for invasive aspergillosis in neutropenic patients: voriconazole or liposomal amphotericin-B? 120
Totale 17.384
Salva come PNG Salva come JPEG
Categoria #
all - tutte 155.580
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 155.580
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021447 0 0 0 0 0 0 0 0 0 72 348 27
2021/20222.205 260 151 34 88 149 76 33 334 115 156 332 477
2022/20234.610 525 562 397 773 365 588 167 373 561 94 158 47
2023/20242.512 126 738 92 81 95 351 203 51 36 91 302 346
2024/20255.995 168 166 398 190 445 150 228 265 960 651 1.360 1.014
2025/202613.711 2.189 373 866 1.469 2.359 1.279 2.359 759 991 1.067 0 0
Totale 38.130